|
3 Companies |
|
1 Product |
|
1 Product |
|
0 Mechanisms of Action |
|
0 Trials |
|
17 News |
|
- | dydrogesterone / Generic mfg.
Trial completion: Randomized Double-blind Controlled Trial of Use of Dydrogesterone in Threatened Miscarriage (clinicaltrials.gov) - Oct 16, 2018
P3, N=406, Completed, Sponsor: The University of Hong Kong
Recruiting --> Completed
- | progesterone - IBSA Institute Biochemical SA, Cedars / Sinai
Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Progesterone in Threatened Abortion (clinicaltrials.gov) - Jul 20, 2018
P3, N=4, Terminated, Sponsor: IBSA Institut Biochimique SA
Recruiting --> Completed N=268 --> 4 | Trial completion date: Nov 2019 --> May 2018 | Recruiting --> Terminated | Trial primary completion date: May 2019 --> May 2018; Difficulty in recruitment
- | dydrogesterone / Generic mfg.
Trial primary completion date: Randomized Double-blind Controlled Trial of Use of Dydrogesterone in Threatened Miscarriage (clinicaltrials.gov) - May 3, 2018
P3, N=400, Recruiting, Sponsor: The University of Hong Kong
N=268 --> 4 | Trial completion date: Nov 2019 --> May 2018 | Recruiting --> Terminated | Trial primary completion date: May 2019 --> May 2018; Difficulty in recruitment Trial primary completion date: Dec 2017 --> May 2018
- |||||| progesterone - IBSA Institute Biochemical SA, Cedars / Sinai
Enrollment open: Progesterone in Threatened Abortion (clinicaltrials.gov) - Jul 11, 2017
P3, N=268, Recruiting, Sponsor: IBSA Institut Biochimique SA
Trial primary completion date: Dec 2017 --> May 2018 Not yet recruiting --> Recruiting
- | progesterone / Generic mfg.
Trial completion, Enrollment change: CLCA125: Corpus Luteum and Uterine Artery Doppler With Serum P and CA125 in Threatened Abortion (clinicaltrials.gov) - Jun 8, 2017
P=N/A, N=100, Completed, Sponsor: Nesreen Abdel Fattah Abdullah Shehata
Not yet recruiting --> Recruiting Recruiting --> Completed | N=200 --> 100
- | progesterone / Generic mfg.
Trial primary completion date: CLCA125: Corpus Luteum and Uterine Artery Doppler With Serum P and CA125 in Threatened Abortion (clinicaltrials.gov) - Mar 21, 2017
P=N/A, N=200, Recruiting, Sponsor: Nesreen Abdel Fattah Abdullah Shehata
Recruiting --> Completed | N=200 --> 100 Trial primary completion date: Dec 2016 --> May 2017
- progesterone / Generic mfg.
Trial primary completion date: CLCA125: Corpus Luteum and Uterine Artery Doppler With Serum P and CA125 in Threatened Abortion (clinicaltrials.gov) - Nov 16, 2016
P=N/A, N=200, Recruiting, Sponsor: Nesreen Abdel Fattah Abdullah Shehata
Trial primary completion date: Dec 2016 --> May 2017 Trial primary completion date: Sep 2016 --> Dec 2016
- | dydrogesterone / Generic mfg.
Enrollment open, Trial initiation date, Trial primary completion date: Randomized Double-blind Controlled Trial of Use of Dydrogesterone in Threatened Miscarriage (clinicaltrials.gov) - Nov 3, 2016
P3, N=400, Recruiting, Sponsor: The University of Hong Kong
Trial primary completion date: Sep 2016 --> Dec 2016 Not yet recruiting --> Recruiting | Initiation date: Dec 2015 --> Mar 2016 | Trial primary completion date: Dec 2016 --> Dec 2017
- |||||||||| progesterone - IBSA Institute Biochemical SA, Cedars / Sinai
New P3 trial: Progesterone in Threatened Abortion (clinicaltrials.gov) - Nov 1, 2016
P3, N=268, Not yet recruiting, Sponsor: IBSA Institut Biochimique SA
- progesterone / Generic mfg.
Enrollment change, Trial withdrawal: Progesterone for First Trimester Vaginal Bleeding (clinicaltrials.gov) - Oct 27, 2016
P=N/A, N=0, Withdrawn, Sponsor: Soroka University Medical Center
Not yet recruiting --> Recruiting | Initiation date: Dec 2015 --> Mar 2016 | Trial primary completion date: Dec 2016 --> Dec 2017 N=200 --> 0 | Not yet recruiting --> Withdrawn
- New trial: POTA: Pregnancy Outcome in Woman With Threatened Abortion (clinicaltrials.gov) - Feb 21, 2016
P=N/A, N=3000, Completed, Sponsor: Bnai Zion Medical Center
- Trial completion, Enrollment change, Trial primary completion date: Pelvic Examination in Pregnancy (clinicaltrials.gov) - Feb 18, 2016
P=N/A, N=270, Completed, Sponsor: Boston Medical Center
N=200 --> 0 | Not yet recruiting --> Withdrawn Recruiting --> Completed | N=800 --> 270 | Trial primary completion date: Jan 2013 --> Jan 2016
- progesterone / Generic mfg.
Trial primary completion date: CLCA125: Corpus Luteum and Uterine Artery Doppler With Serum P and CA125 in Threatened Abortion (clinicaltrials.gov) - Dec 29, 2015
P=N/A, N=200, Recruiting, Sponsor: Nesreen Abdel Fattah Abdullah Shehata
Recruiting --> Completed | N=800 --> 270 | Trial primary completion date: Jan 2013 --> Jan 2016 Trial primary completion date: Jul 2015 --> Jun 2016
- | dydrogesterone / Generic mfg.
Trial initiation date: Randomized Double-blind Controlled Trial of Use of Dydrogesterone in Threatened Miscarriage (clinicaltrials.gov) - Nov 24, 2015
P3, N=400, Not yet recruiting, Sponsor: The University of Hong Kong
Trial primary completion date: Jul 2015 --> Jun 2016 Initiation date: Jan 2015 --> Dec 2015
- || dydrogesterone / Generic mfg.
New P3 trial: Randomized Double-blind Controlled Trial of Use of Dydrogesterone in Threatened Miscarriage (clinicaltrials.gov) - Apr 29, 2014
P3, N=400, Not yet recruiting, Sponsor: The University of Hong Kong